ABSTRACT
A dietary potassium load induces a rapid kaliuresis and natriuresis, which may occur even before plasma potassium and aldosterone (aldo) levels increase. Here we sought to gain insight into underlying molecular mechanisms contributing to this response. After gastric gavage of 2% potassium, the plasma potassium concentrations rose rapidly (0.25 h), followed by a significant rise of plasma aldo (0.5 h) in mice. Enhanced urinary potassium and sodium excretion was detectable as early as spot urines could be collected (about 0.5 h). The functional changes were accompanied by a rapid and sustained (0.25-6 h) dephosphorylation of the NaCl cotransporter (NCC) and a late (6 h) upregulation of proteolytically activated epithelial sodium channels. The rapid effects on NCC were independent from the coadministered anion. NCC dephosphorylation was also aldo-independent, as indicated by experiments in aldo-deficient mice. The observed urinary sodium loss relates to NCC, as it was markedly diminished in NCC-deficient mice. Thus, downregulation of NCC likely explains the natriuretic effect of an acute oral potassium load in mice. This may improve renal potassium excretion by increasing the amount of intraluminal sodium that can be exchanged against potassium in the aldo-sensitive distal nephron.
Subject(s)
Kidney/metabolism , Potassium, Dietary/blood , Receptors, Drug/metabolism , Symporters/metabolism , Administration, Oral , Aldosterone/blood , Animals , Biological Transport , Cytochrome P-450 CYP11B2/deficiency , Cytochrome P-450 CYP11B2/genetics , Epithelial Sodium Channels/metabolism , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Natriuresis , Phosphorylation , Potassium, Dietary/administration & dosage , Potassium, Dietary/urine , Receptors, Drug/deficiency , Receptors, Drug/genetics , Solute Carrier Family 12, Member 3 , Symporters/deficiency , Symporters/genetics , Time Factors , Water-Electrolyte BalanceABSTRACT
The Na-Cl cotransporter (NCC), which is the target of inhibition by thiazides, is located in close proximity to the chloride-absorbing transporter pendrin in the kidney distal nephron. Single deletion of pendrin or NCC does not cause salt wasting or excessive diuresis under basal conditions, raising the possibility that these transporters are predominantly active during salt depletion or in response to excess aldosterone. We hypothesized that pendrin and NCC compensate for loss of function of the other under basal conditions, thereby masking the role that each plays in salt absorption. To test our hypothesis, we generated pendrin/NCC double knockout (KO) mice by crossing pendrin KO mice with NCC KO mice. Pendrin/NCC double KO mice displayed severe salt wasting and sharp increase in urine output under basal conditions. As a result, animals developed profound volume depletion, renal failure, and metabolic alkalosis without hypokalemia, which were all corrected with salt replacement. We propose that the combined inhibition of pendrin and NCC can provide a strong diuretic regimen without causing hypokalemia for patients with fluid overload, including patients with congestive heart failure, nephrotic syndrome, diuretic resistance, or generalized edema.
Subject(s)
Anion Transport Proteins/deficiency , Diuresis/physiology , Receptors, Drug/deficiency , Renal Insufficiency/physiopathology , Sodium Chloride/metabolism , Symporters/deficiency , Alkalosis/blood , Alkalosis/complications , Alkalosis/physiopathology , Animals , Anion Transport Proteins/metabolism , Body Weight , Kidney/pathology , Kidney/physiopathology , Kidney Function Tests , Mice , Mice, Knockout , Models, Biological , Potassium/blood , Receptors, Drug/metabolism , Renal Insufficiency/blood , Renal Insufficiency/complications , Sodium/blood , Sodium Chloride, Dietary , Solute Carrier Family 12, Member 3 , Sulfate Transporters , Symporters/metabolism , Vasopressins/administration & dosage , Vasopressins/pharmacology , Water-Electrolyte Balance/physiologyABSTRACT
OBJECTIVE: Animal and human myocytes demonstrate significant swelling and reduced contractility during exposure to stress (metabolic inhibition, hyposmotic stress, or hyperkalemic cardioplegia), and these detrimental consequences may be inhibited by the addition of diazoxide (adenosine triphosphate-sensitive potassium channel opener) via an unknown mechanism. Both SUR1 and SUR2A subunits have been localized to the heart, and mouse sarcolemmal adenosine triphosphate-sensitive potassium channels are composed of SUR2A/Kir6.2 subunits in the ventricle and SUR1/Kir6.2 subunits in the atria. This study was performed to localize the mechanism of diazoxide by direct probing of sarcolemmal adenosine triphosphate-sensitive potassium channel current and by genetic deletion of channel subunits. METHODS: Sarcolemmal adenosine triphosphate-sensitive potassium channel current was recorded in isolated wild-type ventricular mouse myocytes during exposure to Tyrode's solution, Tyrode's + 100 µmol/L diazoxide, hyperkalemic cardioplegia, cardioplegia + diazoxide, cardioplegia + 100 µmol/L pinacidil, or metabolic inhibition using whole-cell voltage clamp (N = 7-12 cells per group). Ventricular myocyte volume was measured from SUR1(-/-) and wild-type mice during exposure to control solution, hyperkalemic cardioplegia, or cardioplegia + 100 µmol/L diazoxide (N = 7-10 cells per group). RESULTS: Diazoxide did not increase sarcolemmal adenosine triphosphate-sensitive potassium current in wild-type myocytes, although they demonstrated significant swelling during exposure to cardioplegia that was prevented by diazoxide. SUR1(-/-) myocytes also demonstrated significant swelling during exposure to cardioplegia, but this was not altered by diazoxide. CONCLUSIONS: Diazoxide does not open the ventricular sarcolemmal adenosine triphosphate-sensitive potassium channel but provides volume homeostasis via an SUR1-dependent pathway in mouse ventricular myocytes, supporting a mechanism of action distinct from sarcolemmal adenosine triphosphate-sensitive potassium channel activation.
Subject(s)
ATP-Binding Cassette Transporters/agonists , Cardiotonic Agents/pharmacology , Cell Size/drug effects , Diazoxide/pharmacology , KATP Channels/agonists , Myocardial Contraction/drug effects , Myocytes, Cardiac/drug effects , Potassium Channels, Inwardly Rectifying/agonists , Receptors, Drug/agonists , Sarcolemma/drug effects , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Animals , Cardioplegic Solutions/pharmacology , Female , Homeostasis , Hyperkalemia/metabolism , KATP Channels/deficiency , KATP Channels/genetics , KATP Channels/metabolism , Male , Membrane Potentials , Mice , Mice, Knockout , Myocytes, Cardiac/metabolism , Osmotic Pressure , Patch-Clamp Techniques , Pinacidil/pharmacology , Potassium Channels, Inwardly Rectifying/deficiency , Potassium Channels, Inwardly Rectifying/genetics , Potassium Channels, Inwardly Rectifying/metabolism , Receptors, Drug/deficiency , Receptors, Drug/genetics , Receptors, Drug/metabolism , Sarcolemma/metabolism , Sulfonylurea ReceptorsSubject(s)
Hydrochlorothiazide/pharmacology , Kidney Tubules, Collecting/drug effects , Sodium Chloride Symporter Inhibitors/pharmacology , Sodium-Bicarbonate Symporters/antagonists & inhibitors , Absorption/drug effects , Amiloride/pharmacology , Animals , Biological Transport, Active/drug effects , Blood Pressure/physiology , Drug Design , Humans , Hypertension/drug therapy , Kidney Tubules, Collecting/cytology , Kidney Tubules, Collecting/metabolism , Mice , Mice, Knockout , Natriuresis/drug effects , Organ Specificity , Rats , Receptors, Drug/antagonists & inhibitors , Receptors, Drug/deficiency , Receptors, Drug/genetics , Sodium/pharmacokinetics , Sodium-Bicarbonate Symporters/physiology , Solute Carrier Family 12, Member 3 , Symporters/antagonists & inhibitors , Symporters/deficiency , Symporters/geneticsABSTRACT
Spinal cord injury (SCI) is typically complicated by progressive hemorrhagic necrosis, an autodestructive process of secondary injury characterized by progressive enlargement of a hemorrhagic contusion during the first several hours after trauma. We assessed the role of Abcc8, which encodes sulfonylurea receptor 1 (SUR1), in progressive hemorrhagic necrosis. After SCI, humans and rodents exhibited similar regional and cellular patterns of up-regulation of SUR1 and Abcc8 messenger RNA. Elimination of SUR1 in Abcc8(-/-) mice and in rats given antisense oligodeoxynucleotide against Abcc8 prevented progressive hemorrhagic necrosis, yielded significantly better neurological function, and resulted in lesions that were one-fourth to one-third the size of those in control animals. The beneficial effects of Abcc8 suppression were associated with prevention of oncotic (necrotic) death of capillary endothelial cells. Suppression of Abcc8 with antisense oligodeoxynucleotide after SCI presents an opportunity for reducing the devastating sequelae of SCI.
Subject(s)
ATP-Binding Cassette Transporters/metabolism , Potassium Channels, Inwardly Rectifying/metabolism , Receptors, Drug/metabolism , Spinal Cord Injuries/pathology , Spinal Cord Injuries/prevention & control , ATP-Binding Cassette Transporters/genetics , Animals , Disease Models, Animal , Gene Expression Regulation/drug effects , Glyburide/pharmacology , Hemorrhage/complications , Hemorrhage/pathology , Humans , Mice , Mice, Inbred C57BL , Necrosis , Potassium Channels, Inwardly Rectifying/deficiency , Potassium Channels, Inwardly Rectifying/genetics , RNA, Antisense/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Receptors, Drug/deficiency , Receptors, Drug/genetics , Sp1 Transcription Factor/metabolism , Spinal Cord Injuries/physiopathology , Sulfonylurea Receptors , Treatment OutcomeABSTRACT
Trafficking of pancreatic K(ATP) channels to the plasma membrane critically depends on masking the endoplasmic reticulum (ER) retention signals of the SUR1 and Kir6.2 subunits upon their proper assembly into functional hetero-octamers. When expressed in the absence of the partner protein, each subunit might accumulate in the ER and trigger beta-cell ER stress and oxidative stress. To test this hypothesis, Kir6.2 localisation, ER ultra-structure and ER-stress- and oxidative-stress-response gene mRNA levels were evaluated in pancreatic endocrine cells from adult wild-type (WT) and Sur1 knockout (Sur1 ( -/- )) mice. As previously reported, Kir6.2 was mainly expressed on secretory granules and at the plasma membrane of WT islet cells. In contrast, like the ER chaperone calreticulin, Kir6.2 was primarily localised in the rough endoplasmic reticulum (RER) of Sur1 ( -/- ) islet cells. ER retention of Kir6.2 was demonstrated (electron microscopy) by a significant increase in the length and Kir6.2 density of RER in Sur1 ( -/- ) vs WT islet cells. Despite Kir6.2 retention in RER, Xbp1 mRNA splicing and mRNA levels of preproinsulin and ER-stress-response genes Bip, Edem and Gadd153 were similar in WT and Sur1 ( -/- ) islets. However, mRNA levels of the antioxidant enzymes Sod1, Sod2, Gpx2 and catalase were significantly up-regulated in Sur1 ( -/- ) islets. Sequestration of Kir6.2 in RER of Sur1 ( -/- ) islet cells is thus associated with an increase in RER length and mild oxidative stress without activation of the classical ER stress response.
Subject(s)
Endoplasmic Reticulum/metabolism , Islets of Langerhans/metabolism , Potassium Channels, Inwardly Rectifying/deficiency , Potassium Channels, Inwardly Rectifying/metabolism , Receptors, Drug/deficiency , Stress, Physiological , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Animals , Antibody Specificity/immunology , Calreticulin/metabolism , Endoplasmic Reticulum/genetics , Endoplasmic Reticulum/ultrastructure , Gene Expression Regulation , Islets of Langerhans/cytology , Islets of Langerhans/ultrastructure , Mice , Mice, Inbred C57BL , Mice, Knockout , Oxidative Stress/genetics , Potassium Channels, Inwardly Rectifying/genetics , Protein Transport , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Drug/genetics , Receptors, Drug/metabolism , Subcellular Fractions/metabolism , Sulfonylurea ReceptorsABSTRACT
The mammalian CNS relies on a constant supply of external glucose for its undisturbed operation. However, neurons can readily switch to using fatty acids and ketones as alternative fuels. Here, we show that oleic acid (OA) excites pro-opiomelanocortin (POMC) neurons by inhibition of ATP-activated potassium (K(ATP)) channels. The involvement of K(ATP) channels is further supported by experiments in SUR1 KO animals. Inhibition of beta-oxidation using carnitine palmitoyltransferase-1 inhibitors blocks OA-induced depolarization. The depolarizing effect of OA is specific because it is not mimicked by octanoic acid. Furthermore, OA does not regulate the excitability of agouti-related peptide neurons. High-fat feeding alters POMC neuron excitability, but not its response to OA. Thus beta-oxidation in POMC neurons may mediate the appetite-suppressing (anorexigenic) effects of OA.
Subject(s)
Hypothalamus/cytology , Neurons/drug effects , Oleic Acid/pharmacology , Pro-Opiomelanocortin/metabolism , ATP-Binding Cassette Transporters , Action Potentials/drug effects , Action Potentials/genetics , Adenosine Triphosphate/pharmacology , Analysis of Variance , Animals , Biophysics , Diazoxide/pharmacology , Dietary Fats/administration & dosage , Dose-Response Relationship, Drug , Electric Stimulation/methods , Glucose/metabolism , Glyburide/pharmacology , Green Fluorescent Proteins/genetics , Hypoglycemic Agents/pharmacology , In Vitro Techniques , Mice , Mice, Transgenic , Models, Biological , Neural Inhibition/drug effects , Neural Inhibition/physiology , Neurons/metabolism , Patch-Clamp Techniques/methods , Potassium Channel Blockers , Potassium Channels, Inwardly Rectifying/deficiency , Potassium Channels, Inwardly Rectifying/drug effects , Potassium Channels, Inwardly Rectifying/physiology , Pro-Opiomelanocortin/genetics , Receptors, Drug/deficiency , Sulfonylurea ReceptorsABSTRACT
In congenital hyperinsulinism of infancy (CHI), the loss of K-ATP channels (composed of Kir6.2 and SUR1 subunits) in beta cells induces permanent insulin secretion and severe hypoglycaemia. By contrast, Sur1 ( -/- ) mice do not present such defects. We have investigated the impact of Sur1 gene inactivation on mouse islet cell morphology, structure and basic physiology. Pancreata were collected from young, adult and old wild-type (WT) and Sur1 ( -/- ) mice. After immunostaining for hormone, the total endocrine tissue, cell proportion, cell size and intra-insular distribution, hormone content and Glut-2 expression were quantified by morphometry. Basic physiological parameters were also measured. In young Sur1 ( -/- ) mice, the total endocrine tissue and proportion of beta cells were higher (P<0.05) than in WT mice, whereas the proportion of delta cells was lower (P<0.01). In old Sur1 ( -/- ) mice, alpha cells were frequently located in the central regions of islets (unlike WT islets) and their proportion was increased (P<0.05). Glut-2 protein and mRNA levels were lower in old Sur1 ( -/- ) islets (P<0.02). Insulinaemia, fasting insulin and glucagon contents were equivalent in both groups of pancreata. Thus, the islets of Sur1 ( -/- ) mice present morphological modifications that have not been described in CHI and that might reflect an adaptive mechanism controlling insulin secretion in these mice.
Subject(s)
ATP-Binding Cassette Transporters/genetics , Islets of Langerhans/physiology , Pancreas/physiology , Potassium Channels, Inwardly Rectifying/genetics , Receptors, Drug/genetics , Age Factors , Animals , Blood Glucose/metabolism , Female , Gene Silencing , Glucagon/genetics , Glucagon/metabolism , Immunohistochemistry , Insulin/blood , Insulin/metabolism , Insulin Secretion , Islets of Langerhans/cytology , Islets of Langerhans/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Pancreas/anatomy & histology , Pancreas/cytology , Pancreas/metabolism , Potassium Channels, Inwardly Rectifying/deficiency , Receptors, Drug/deficiency , Sulfonylurea ReceptorsABSTRACT
ATP-sensitive K+ (KATP) channel openers are vasodilators that activate both plasma membrane and mitochondrial KATP channels. Here, we investigated the molecular mechanisms by which diazoxide and pinacidil induce vasodilation by studying diameter regulation of wild-type [SUR2(+/+)] and sulfonylurea receptor (SUR) 2-deficient [SUR2(-/-)] mouse myogenic mesenteric arteries. Ryanodine (10 microM), a ryanodine-sensitive Ca2+ release (RyR) channel blocker; iberiotoxin (100 nM), a large-conductance Ca2+-activated K+ (KCa) channel blocker; 4-aminopyridine (4-AP; 1 mM), a voltage-gated K+ (KV) channel blocker; manganese(III) tetrakis(1-methyl-4-pyridyl)porphyrin (MnTMPyP; 100 microM), an antioxidant; and a combination of ryanodine and 4-AP reduced diazoxide (100 microM)-induced dilation in pressurized (60 mm Hg) SUR2(+/+) arteries by 45 to 77%. In contrast, these inhibitors did not alter pinacidil (5 microM)-induced dilation in SUR2(+/+) arteries. Reverse transcription-polymerase chain reaction indicated that SUR2B was the only SUR isoform expressed in SUR2(+/+) mesenteric artery smooth muscle cells, whereas SURs were absent in SUR2(-/-) cells. In SUR2(-/-) arteries, pinacidil-induced vasodilation was 10% of that in SUR2(+/+) arteries, whereas diazoxide-induced vasodilation was similar in SUR2(+/+) and SUR2(-/-) arteries. Atpenin (1 microM), a selective electron transport chain (ETC) complex II inhibitor, dilated arteries similarly to diazoxide, and this effect was attenuated by MnTMPyP and ryanodine + 4-AP. Atpenin also attenuated diazoxide-, but not pinacidil-induced vasodilation. In summary, data indicate that pinacidil-induced vasodilation requires SUR2B, whereas diazoxide-induced vasodilation does not require SURs. Rather, diazoxide-induced vasodilation involves ETCII inhibition; a smooth muscle cell-reactive oxygen species elevation; and RyR, KCa, and KV channel activation. These data indicate that KATP channel openers regulate arterial diameter via SUR-dependent and -independent pathways.
Subject(s)
ATP-Binding Cassette Transporters/metabolism , Adenosine Triphosphate/pharmacology , Membrane Transport Modulators/pharmacology , Potassium Channels, Inwardly Rectifying/metabolism , Potassium Channels/metabolism , Receptors, Drug/metabolism , Vasodilation/drug effects , Animals , Blood Pressure/drug effects , Diazoxide/pharmacology , Electron Transport Complex II/antagonists & inhibitors , Endothelium/drug effects , Endothelium/metabolism , In Vitro Techniques , Ion Channel Gating/drug effects , Mesenteric Arteries/cytology , Mesenteric Arteries/drug effects , Mice , Muscle Cells/drug effects , Muscle Cells/metabolism , Pinacidil/pharmacology , Potassium Channels, Inwardly Rectifying/deficiency , Protein Subunits/metabolism , Receptors, Drug/deficiency , Ryanodine Receptor Calcium Release Channel/metabolism , Sulfonylurea ReceptorsABSTRACT
K(ATP) channel activity influences beta cell Ca(2+) homeostasis by regulating Ca(2+) influx through L-type Ca(2+) channels. The present paper demonstrates that loss of K(ATP) channel activity due to pharmacologic or genetic ablation affects Ca(2+) storage in intracellular organelles. ATP depletion, by the mitochondrial inhibitor FCCP, led to Ca(2+) release from the endoplasmic reticulum (ER) of wildtype beta cells. Blockade of ER Ca(2+) ATPases by cyclopiazonic acid abolished the FCCP-induced Ca(2+) transient. In beta cells treated with K(ATP) channel inhibitors FCCP elicited a significantly larger Ca(2+) transient. Cyclopiazonic acid did not abolish this Ca(2+) transient suggesting that non-ER compartments are recruited as additional Ca(2+) stores in beta cells lacking K(ATP) channel activity. Genetic ablation of K(ATP) channels in SUR1KO mice produced identical results. In INS-1 cells transfected with a mitochondrial-targeted Ca(2+)-sensitive fluorescence dye (ratiometric pericam) the increase in mitochondrial Ca(2+) evoked by tolbutamide was 5-fold larger compared to 15 mM glucose. These data show that genetic or pharmacologic ablation of K(ATP) channel activity conveys Ca(2+) release from a non-ER store. Based on the sensitivity to FCCP and the property of tolbutamide to increase mitochondrial Ca(2+) it is suggested that mitochondria are the recruited store. The change in Ca(2+) sequestration in beta cells treated with insulinotropic antidiabetics may have implications for beta cell survival and the therapeutic use of these drugs.
Subject(s)
Calcium/metabolism , Insulin-Secreting Cells/metabolism , Potassium Channels/metabolism , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Animals , Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone/pharmacology , Cell Compartmentation , Cell Line , Cytosol/metabolism , Endoplasmic Reticulum/metabolism , Glucose/pharmacology , In Vitro Techniques , Insulin-Secreting Cells/drug effects , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondria/metabolism , Potassium Channels/deficiency , Potassium Channels/genetics , Potassium Channels, Inwardly Rectifying/deficiency , Potassium Channels, Inwardly Rectifying/genetics , Potassium Channels, Inwardly Rectifying/metabolism , Receptors, Drug/deficiency , Receptors, Drug/genetics , Receptors, Drug/metabolism , Sulfonylurea Receptors , Tolbutamide/pharmacologyABSTRACT
Sulfonylurea receptors (SURs) constitute the regulatory subunits of ATP-sensitive K+ channels (K(ATP) channels). SUR binds nucleotides and synthetic K(ATP) channel modulators, e.g. the antidiabetic sulfonylurea glibenclamide, which acts as a channel blocker. However, knowledge about naturally occurring ligands of SUR is very limited. In this study, we show that the plant phenolic compound trans-resveratrol can bind to SUR and displace binding of glibenclamide. Electrophysiological measurements revealed that resveratrol is a blocker of pancreatic SUR1/K(IR)6.2 K(ATP) channels. We further demonstrate that, like glibenclamide, resveratrol induces enhanced apoptosis. This was shown by analyzing different apoptotic parameters (cell detachment, nuclear condensation and fragmentation, and activities of different caspase enzymes). The observed apoptotic effect was specific to cells expressing the SUR1 isoform and was not mediated by the electrical activity of K(ATP) channels, as it was observed in human embryonic kidney 293 cells expressing SUR1 alone. Enhanced susceptibility to resveratrol was not observed in pancreatic beta-cells from SUR1 knock-out mice or in cells expressing the isoform SUR2A or SUR2B or the mutant SUR1(M1289T). Resveratrol was much more potent than glibenclamide in inducing SUR1-specific apoptosis. Treatment with etoposide, a classical inducer of apoptosis, did not result in SUR isoform-specific apoptosis. In conclusion, resveratrol is a natural SUR ligand that can induce apoptosis in a SUR isoform-specific manner. Considering the tissue-specific expression patterns of SUR isoforms and the possible effects of SUR mutations on susceptibility to apoptosis, these observations could be important for diabetes and/or cancer research.
Subject(s)
ATP-Binding Cassette Transporters/physiology , Apoptosis/physiology , Potassium Channels, Inwardly Rectifying/physiology , Potassium Channels/physiology , Receptors, Drug/physiology , Stilbenes/pharmacology , ATP-Binding Cassette Transporters/drug effects , ATP-Binding Cassette Transporters/genetics , Animals , Apoptosis/drug effects , Caspases/drug effects , Caspases/metabolism , Cell Adhesion/drug effects , Cell Line , Etoposide/pharmacology , Female , Humans , Hypoglycemic Agents/pharmacology , Islets of Langerhans/cytology , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Islets of Langerhans/physiology , Kidney , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Potassium Channels/deficiency , Potassium Channels/drug effects , Potassium Channels/genetics , Potassium Channels, Inwardly Rectifying/deficiency , Potassium Channels, Inwardly Rectifying/drug effects , Potassium Channels, Inwardly Rectifying/genetics , Receptors, Drug/deficiency , Receptors, Drug/drug effects , Receptors, Drug/genetics , Recombinant Proteins/drug effects , Recombinant Proteins/metabolism , Resveratrol , Stilbenes/pharmacokinetics , Sulfonylurea Receptors , TransfectionABSTRACT
AIMS/HYPOTHESIS: Islets or beta cells from Sur1(-/-) mice were used to determine whether changes in plasma membrane potential (V(m)) remain coupled to changes in cytosolic Ca(2+) ([Ca(2+)](i)) in the absence of K(ATP) channels and thus provide a triggering signal for insulin secretion. The study also sought to elucidate whether [Ca(2+)](i) influences oscillations in V(m) in sur1(-/-) beta cells. METHODS: Plasma membrane potential and ion currents were measured with microelectrodes and the patch-clamp technique. [Ca(2+)](i) was monitored with the fluorescent dye fura-2. Insulin secretion from isolated islets was determined by static incubations. RESULTS: Membrane depolarisation of Sur1(-/-) islets by arginine or increased extracellular K(+), elevated [Ca(2+)](i) and augmented insulin secretion. Oligomycin completely abolished glucose-stimulated insulin release from Sur1(-/-) islets. Oscillations in V(m) were influenced by [Ca(2+)](i) as follows: (1) elevation of extracellular Ca(2+) lengthened phases of membrane hyperpolarisation; (2) simulating a burst of action potentials induced a Ca(2+)-dependent outward current that was augmented by increased Ca(2+) influx through L-type Ca(2+) channels; (3) Ca(2+) depletion of intracellular stores by cyclopiazonic acid increased the burst frequency in Sur1(-/-) islets, elevating [Ca(2+)](i) and insulin secretion; (4) store depletion activated a Ca(2+) influx that was not inhibitable by the L-type Ca(2+) channel blocker D600. CONCLUSIONS/INTERPRETATION: Although V(m) is largely uncoupled from glucose metabolism in the absence of K(ATP) channels, increased electrical activity leads to elevations of [Ca(2+)](i) that are sufficient to stimulate insulin secretion. In Sur1(-/-) beta cells, [Ca(2+)](i) exerts feedback mechanisms on V(m) by activating a hyperpolarising outward current and by depolarising V(m) via store-operated ion channels.
Subject(s)
ATP-Binding Cassette Transporters/genetics , Calcium/metabolism , Insulin/metabolism , Islets of Langerhans/physiology , Membrane Potentials/physiology , Potassium Channels, Inwardly Rectifying/genetics , Potassium Channels/genetics , Receptors, Drug/genetics , Animals , Arginine/pharmacology , Cell Membrane/physiology , Indoles/pharmacology , Insulin Secretion , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Mice , Mice, Knockout , Patch-Clamp Techniques , Potassium/pharmacology , Potassium Channels/deficiency , Potassium Channels, Inwardly Rectifying/deficiency , Receptors, Drug/deficiency , Sulfonylurea ReceptorsABSTRACT
Vanilloid receptor 1 (TRPV1) has been proposed to be the principal heat-responsive channel for nociceptive neurons. The skin of both rat and mouse receives major projections from primary sensory afferents that bind the plant lectin isolectin B4 (IB4). The majority of IB4-positive neurons are known to be heat-responsive nociceptors. Previous studies suggested that, unlike rat, mouse IB4-positive cutaneous afferents did not express TRPV1 immunoreactivity. Here, multiple antisera were used to confirm that mouse and rat have different distributions of TRPV1 and that TRPV1 immunoreactivity is absent in heat-sensitive nociceptors. Intracellular recording in TRPV1(-/-) mice was then used to confirm that TRPV1 was not required for detecting noxious heat. TRPV1(-/-) mice had more heat-sensitive neurons, and these neurons had normal temperature thresholds and response properties. Moreover, in TRPV1(-/-) mice, 82% of heat-responsive neurons did not express immunoreactivity for TRPV2, another putative noxious heat channel.
Subject(s)
Calcium Channels/deficiency , Ganglia, Spinal/cytology , Hot Temperature , Ion Channels/deficiency , Neurons, Afferent/chemistry , Nociceptors/physiology , Receptors, Drug/deficiency , Amino Acid Sequence , Animals , Calcium Channels/genetics , Calcium Channels/physiology , Epidermis/physiology , Female , Ion Channels/genetics , Ion Channels/physiology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C3H , Molecular Sequence Data , Neurons, Afferent/physiology , Nociceptors/chemistry , Plant Lectins/analysis , Rats , Rats, Sprague-Dawley , Receptors, Drug/genetics , Receptors, Drug/physiology , Species Specificity , TRPV Cation ChannelsABSTRACT
Sensory irritants initiate respiratory reflexes by stimulating trigeminal sensory nerves. The vanilloid receptor (TRPV1) is expressed on sensory C fibers. The current experiments were aimed at examining the role of this receptor in mediating responses to several airborne irritants including an acidic (acetic acid), electrophilic (acrolein), and lipophilic solvent (styrene) vapor. Wild-type (C57Bl/6J) and VR1 knockout [B6.129S4-VR1(tm1jul)] mice were exposed to these irritants and breathing pattern responses were assessed by plethysmographic techniques; both wild-type and knockout animals responded similarly to the irritants. The TRPV1 antagonist iodoresiniferatoxin was also without effect on the responses to the irritants. Thus, in the C57Bl/6J mouse the TRPV1 receptor does not appear to play a major role in the stimulation of nasal trigeminal central reflex responses by these irritant air pollutants.
Subject(s)
Air Pollutants/pharmacology , Inhalation/drug effects , Receptors, Drug/physiology , Acetic Acid/pharmacology , Acrolein/pharmacology , Animals , Female , Inhalation/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Drug/deficiency , Receptors, Drug/genetics , Styrene/pharmacologyABSTRACT
Proteinase-activated receptor (PAR) 2 is expressed on a subset of primary afferent neurons and involved in inflammatory nociception. Transient receptor potential vanilloid subfamily 1 (TRPV1) is a sensory neuron-specific cation channel that responds to capsaicin, protons, or heat stimulus. Here, we show that TRPV1 is coexpressed with PAR2 but not with PAR1 or PAR3, and that TRPV1 can functionally interact with PAR2. In human embryonic kidney 293 cells expressing TRPV1 and PAR2, PAR2 agonists increased capsaicin- or proton-evoked TRPV1 currents through a PKC-dependent pathway. After application of PAR2 agonists, temperature threshold for TRPV1 activation was reduced from 42 degrees C to well below the body temperature. PAR2-mediated Fos expression in spinal cord was decreased in TRPV1-deficient mice. The functional interaction was also observed in mouse DRG neurons and proved at a behavioral level. These represent a novel mechanism through which trypsin or tryptase released in response to tissue inflammation might trigger the sensation of pain by PAR2 activation.
Subject(s)
Endopeptidases/metabolism , Inflammation/physiopathology , Pain/physiopathology , Receptor, PAR-2/metabolism , Receptors, Drug/metabolism , Animals , Cells, Cultured , Enzyme Inhibitors/pharmacology , Ganglia, Spinal/metabolism , Ganglia, Spinal/pathology , Humans , Hyperalgesia/genetics , Hyperalgesia/physiopathology , Inflammation/enzymology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Pain/enzymology , Patch-Clamp Techniques , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , Proto-Oncogene Proteins c-fos/metabolism , Receptor, PAR-1/genetics , Receptor, PAR-1/metabolism , Receptor, PAR-2/agonists , Receptor, PAR-2/genetics , Receptors, Drug/deficiency , Receptors, Drug/genetics , Receptors, Thrombin/genetics , Receptors, Thrombin/metabolism , Signal Transduction/physiology , Spinal Cord/metabolism , Spinal Cord/pathology , Temperature , TransfectionABSTRACT
Effects of the endogenous lipid N-oleoyldopamine (OLDA) were analyzed on the rTRPV1-expressing HT1080 human fibrosarcoma cell line (HT5-1), on cultured rat trigeminal neurons, on the noxious heat threshold of rats and on nocifensive behavior of TRPV1 knockout mice. The EC(50) of capsaicin and OLDA on (45)Ca accumulation of rTRPV1-expressing HT5-1 cells was 36 nM and 1.8 microM, respectively. The efficacy of OLDA was 60% as compared to the maximum response of capsaicin. OLDA (330 nM to 3.3 microM) caused a transient increase in fluorescence of fura-2 loaded cultured small trigeminal neurons of the rat and rTRPV1-transfected HT5-1 cells measured with a ratiometric technique. Repeated application of OLDA and capsaicin caused similar desensitization in the Ca(2+) transients both in cultured neurons and rTRPV1-transfected HT5-1 cells. In the rat intraplantar injection of OLDA (5 nmol) decreased the noxious heat threshold by 6-9 degrees C and this response was strongly inhibited by the TRPV1 antagonist iodoresiniferatoxin (0.05 nmol intraplantarly (i.pl.)). In wild-type mice OLDA (50 nmol i.pl.) evoked paw lifting/licking which was significantly less sustained in TRPV1 knockout mice. It is concluded that on TRPV1 capsaicin receptors OLDA is 50 times less potent than capsaicin and it might serve as an endogenous ligand for TRPV1 in the rat, but more likely in humans.
Subject(s)
Dopamine/analogs & derivatives , Dopamine/pharmacology , Pain/chemically induced , Receptors, Drug/drug effects , Receptors, Drug/deficiency , Animals , Behavior, Animal/drug effects , Behavior, Animal/physiology , Calcium Signaling/drug effects , Calcium Signaling/physiology , Capsaicin/pharmacology , Cell Line, Tumor , Dose-Response Relationship, Drug , Hot Temperature/adverse effects , Humans , Ligands , Mice , Mice, Knockout , Neurons, Afferent/drug effects , Neurons, Afferent/physiology , Nociceptors/drug effects , Nociceptors/metabolism , Pain/genetics , Pain/metabolism , Pain Threshold/drug effects , Pain Threshold/physiology , Rats , Receptors, Drug/genetics , TransfectionABSTRACT
Daily body temperature (DBT) rhythm of mice lacking one of the transient receptor potential (TRP) family of proteins, the capsaicin receptor or TRPV1, was recorded by biotelemetry and found to have significantly higher amplitude than that of wild-type mice. Capsaicin-desensitized wild-mice exhibited an even higher DBT amplitude than did TRPV1 deficient mice. A standard heat load (radiant temperature of 36-37 degrees C) resulted in similar rises in body core temperature in wild-type mice and in TRPV1 deficient mice, while capsaicin-desensitized wild-type mice exhibited a robust heat-intolerance. The lack of TRPV1 slightly modifies amplitude of daily body temperature rhythm but does not seem to influence physiological heat defence in mice. In vivo evidence for a TRP protein functioning in the physiological heat-defence range is still lacking.
Subject(s)
Body Temperature/physiology , Capsaicin/pharmacology , Circadian Rhythm/physiology , Hot Temperature , Receptors, Drug/deficiency , Animals , Body Temperature/drug effects , Circadian Rhythm/drug effects , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Drug/agonists , Receptors, Drug/geneticsABSTRACT
The vanilloid receptor TRPV1 (formerly VR1) has been implicated in the activation of nociceptive sensory nerves by capsaicin, noxious heat, protons, bradykinin, cannabinoids such as anandamide, and certain metabolites of arachidonic acid. Using TRPV1 knockout mouse (TRPV1-/-) we address the question of whether TRPV1 is obligatory for action potential discharge in vagal C-fibre terminals evoked by capsaicin, anandamide, acid and bradykinin. The response of a defined subtype of the vagal afferent bronchopulmonary C-fibres (conduction velocity < 0.7 ms(-1)) to the putative TRPV1 activators was studied in vitro in the mouse isolated/perfused lung-nerve preparation. Capsaicin (1 microm) evoked action potential discharge of approximately 90% (28/31) of C-fibres in the TRPV1+/+ mice, but failed to activate bronchopulmonary C-fibres in TRPV1-/- animals (n = 10). Anandamide (3-100 microm) induced concentration-dependent activation of capsaicin-sensitive TRPV1+/+ C-fibres with a threshold of 3-10 microm, but failed to evoke substantive discharge in TRPV1-/- C-fibres. In the TRPV1+/+ mice, the B2 receptor-mediated activation by bradykinin (1 microm) was restricted to the capsaicin-sensitive C-fibres. Bradykinin was effective in evoking B2 receptor-mediated action potential discharge in TRPV1-/- C-fibres, but the response was significantly (P < 0.05) less persistent than in TRPV1+/+ C-fibres. Exposing the tissue to acid (pH = 5) excited both TRPV1+/+ and TRPV1-/- C-fibres. We conclude that TRPV1 is obligatory for vagal C-fibre activation by capsaicin and anandamide. By contrast, whereas TRPV1 may have a modulatory role in bradykinin and acid-induced activation of bronchopulmonary C-fibres, it is not required for action potential discharge evoked by these stimuli.
Subject(s)
Bradykinin/pharmacology , Lung/physiology , Receptors, Drug/agonists , Receptors, Drug/deficiency , Vagus Nerve/physiology , Action Potentials/drug effects , Action Potentials/physiology , Afferent Pathways/drug effects , Afferent Pathways/physiology , Animals , Arachidonic Acids/pharmacology , Dose-Response Relationship, Drug , Endocannabinoids , In Vitro Techniques , Lung/drug effects , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Fibers, Unmyelinated/drug effects , Nerve Fibers, Unmyelinated/physiology , Polyunsaturated Alkamides , Receptors, Drug/genetics , Vagus Nerve/drug effectsABSTRACT
Cell death mechanisms frequently involve the influx of extracellular calcium through voltage- and ligand-gated ion channels, e.g., the NMDA receptor (Greene, 1999). The vanilloid receptor (VR1) is present in regions of the brain (Mezey et al., 2000) that are highly susceptible to neurodegenerative insults, suggesting that this ion channel might contribute to the cellular processes involved in neuronal death. We tested the effects of VR1 ligands in the oxygen glucose deprivation (OGD) model of cell death in organotypic hippocampal slice cultures. The VR1 agonist capsaicin at concentrations that are selective for VR1 did not affect cell viability per se or the extent of neurodegeneration induced by the OGD insult. In contrast, the VR1 antagonist capsazepine (0.1-10 microm) significantly reduced the amount of OGD-induced cell death. However, capsazepine was still neuroprotective in slices prepared from VR1 knock-out mice, which exhibited the same degree of neurodegeneration to that observed in slices prepared from wild-type mice, excluding the possibility that it afforded neuroprotection through inhibition of VR1. Instead, capsazepine inhibited the hyperpolarization-activated nonspecific cation channel generated current I(h) in a concentration range similar to that which was neuroprotective. Furthermore, the specific I(h) blocker ZD-7288 was also neuroprotective, mirroring the effects of capsazepine, in that it was effective at preventing cell death when applied either during or after the OGD insult. These results demonstrate that capsazepine affords neuroprotection through inhibition of I(h) rather than inhibition of VR1.
Subject(s)
Capsaicin/analogs & derivatives , Capsaicin/pharmacology , Cell Hypoxia/physiology , Glucose/metabolism , Ion Channels/antagonists & inhibitors , Nerve Tissue Proteins , Neurons/drug effects , Neurons/metabolism , Animals , Cell Death , Cells, Cultured , Cyclic Nucleotide-Gated Cation Channels , Cytoprotection/drug effects , Cytoprotection/physiology , Dose-Response Relationship, Drug , Glucose/deficiency , Hippocampus/cytology , Hippocampus/drug effects , Hippocampus/metabolism , Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels , In Vitro Techniques , Ion Channels/metabolism , Mice , Mice, Knockout , Neuroprotective Agents/pharmacology , Patch-Clamp Techniques , Potassium Channels , Rats , Rats, Sprague-Dawley , Receptors, Drug/deficiency , Receptors, Drug/geneticsABSTRACT
The cannabinoid receptor type 1 (CB1) and its endogenous ligands, the endocannabinoids, are involved in the regulation of food intake. Here we show that the lack of CB1 in mice with a disrupted CB1 gene causes hypophagia and leanness. As compared with WT (CB1+/+) littermates, mice lacking CB1 (CB1-/-) exhibited reduced spontaneous caloric intake and, as a consequence of reduced total fat mass, decreased body weight. In young CB1-/- mice, the lean phenotype is predominantly caused by decreased caloric intake, whereas in adult CB1-/- mice, metabolic factors appear to contribute to the lean phenotype. No significant differences between genotypes were detected regarding locomotor activity, body temperature, or energy expenditure. Hypothalamic CB1 mRNA was found to be coexpressed with neuropeptides known to modulate food intake, such as corticotropin-releasing hormone (CRH), cocaine-amphetamine-regulated transcript (CART), melanin-concentrating hormone (MCH), and preproorexin, indicating a possible role for endocannabinoid receptors within central networks governing appetite. CB1-/- mice showed significantly increased CRH mRNA levels in the paraventricular nucleus and reduced CART mRNA levels in the dorsomedial and lateral hypothalamic areas. CB1 was also detected in epidydimal mouse adipocytes, and CB1-specific activation enhanced lipogenesis in primary adipocyte cultures. Our results indicate that the cannabinoid system is an essential endogenous regulator of energy homeostasis via central orexigenic as well as peripheral lipogenic mechanisms and might therefore represent a promising target to treat diseases characterized by impaired energy balance.